Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance of Healing of Erosive Esophagitis in Pediatric Patients Treated with NEXIUM
2020-002515-21Phase 3Suspended
- Sponsor
- AstraZeneca
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of esomeprazole in erosive esophagitis (EE), sponsored by AstraZeneca. Primary endpoints: Maintenance phase efficacy and Maintenance phase safety. Started Jul 2021; status: suspended.
02
Drugs
esomeprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on 2020-002515-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002515-21.